Pyridopyrazine derivatives, process of manufacturing and uses thereof
AssigneeAEterna Zentaris GmbH
InventorsMatthias Gerlach, Irene Seipelt, Eckhard Guenther, Emmanuel Polymeropoulos, Tilmann Schuster, Eckhard Claus
Life of this patent
Estimating the term…
Abstract
1-ethyl-3-[3-(1-methyl-1H-pyrazol-4-yl)-pyrido[2.3-b]pyrazine-6-yl]thiourea which HAS activity to the modulation of misdirected cellular signal transduction processes such as tyrosine kinases, serine/threonine kinases and/or lipid kinases.
Claims3
A compound 1-ethyl-3-(3-(1-methyl-1H-pyrazol-4-yl)pyrido[2,3-b]pyrazin-6-yl)thiourea.
A pharmaceutical composition comprising 1-ethyl-3-(3-(1-methyl-1H-pyrazol-4-yl)pyrido[2,3-b]pyrazin-6-yl)thiourea and a pharmaceutically acceptable carrier and/or pharmaceutically acceptable auxiliary.
Dependencies are inferred from the claim text.